SCHEMBL3140997

SCHEMBL3140997

Cc1cc(C)c2cc(Oc3c(Br)cc(CCC(=O)O)cc3Br)ccc2n1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRA P10827 15/20 0.55
THRB P10828 15/20 0.55
KDM4E B2RXH2 3/20 0.44
FFAR1 O14842 1/20 0.43
PCNA P12004 2/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
HIF1A Q16665 1/20 0.42
ESR1 P03372 1/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
NR3C2 P08235 1/20 0.41
AR P10275 1/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129896 0.89 THRA (0.53) THRATHRBKDM4EPCNAPOLB
SCHEMBL3145813 0.87 THRA (0.52) THRATHRBKDM4EFFAR1PCNA
SCHEMBL3145340 0.87 THRA (0.55) THRATHRBKDM4EFFAR1PCNA
SCHEMBL3136444 0.86 THRA (0.50) THRATHRBKDM4EPCNAPOLB
SCHEMBL3137369 0.85 THRA (0.56) THRATHRBFFAR1PCNAPOLB
SCHEMBL3142092 0.83 KDM4E (0.46) THRATHRBKDM4EPOLBHPGD
SCHEMBL3137244 0.79 THRA (0.54) THRATHRBPCNAPOLBMAPK1
SCHEMBL3145868 0.79 THRA (0.54) THRATHRBFFAR1SMN1; SMN2
SCHEMBL5074377 0.78 CYP1A2 (0.46) KDM4EPOLBHPGDHSD17B10ALDH1A1
SCHEMBL3135791 0.78 KDM4E (0.43) THRATHRBKDM4EPOLBESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004271-A1 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR KARO BIO AB (SE) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004271-A1 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR TSHR, GHSR, TRHR THRA 4/4885THRB 6/4885KDM4E 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.